Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,062
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular
Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States
Anshul Shaha Evidera, Mumbai, India
, Firas Dabbousb Evidera Inc., Bethesda, MD, USACorrespondence[email protected]
, Surbhi Shahc Evidera Inc., Waltham, MA, USA
, Veronica Ashtond Janssen Scientific Affairs LLC, Titusville, NJ, USA
& Akshay Kharatd Janssen Scientific Affairs LLC, Titusville, NJ, USA
Pages 10-15
|
Received 15 Sep 2023, Accepted 29 Nov 2023, Published online: 09 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.